Protara Therapeutics Inc (TARA)
3.10
-0.64
(-17.11%)
USD |
NASDAQ |
May 17, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Accounts Payable (Quarterly): 0.972M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.972M |
| December 31, 2023 | 2.434M |
| September 30, 2023 | 2.504M |
| June 30, 2023 | 1.852M |
| March 31, 2023 | 4.081M |
| December 31, 2022 | 1.586M |
| September 30, 2022 | 0.456M |
| June 30, 2022 | 0.392M |
| March 31, 2022 | 0.541M |
| December 31, 2021 | 0.954M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.928M |
| June 30, 2021 | 1.403M |
| March 31, 2021 | 1.853M |
| December 31, 2020 | 0.914M |
| September 30, 2020 | 1.913M |
| June 30, 2020 | 0.9152M |
| March 31, 2020 | 2.650M |
| December 31, 2019 | 0.716M |
| September 30, 2019 | 0.147M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.147M
Minimum
Sep 2019
4.081M
Maximum
Mar 2023
1.432M
Average
0.972M
Median
Mar 2024
Accounts Payable (Quarterly) Benchmarks
| AngioDynamics Inc | 35.15M |
| Regulus Therapeutics Inc | 0.406M |
| Bio-Path Holdings Inc | 0.457M |
| Outset Medical Inc | 6.773M |
| NovaBay Pharmaceuticals Inc | 1.117M |